PROJECT TEAM
Tejs Jansen, MD, PhD, senior consultant, Dept. of Neurointensive care, The Innovation lab, Copenhagen University Hospital
THE NEED
Depression affects 200,000–300,000 people in Denmark every year, and 20–30% of patients do not respond to standard treatments such as medication or psychotherapy. Existing second-line therapies like transcranial magnetic stimulation (TMS) require frequent hospital sessions over several weeks, which is both costly and inconvenient for patients.
THE SOLUTION
The system uses neuroimaging sensors to monitor brain activity and deliver low-intensity electromagnetic stimulation targeting disrupted brain circuits. It is designed for home use, with feedback and monitoring provided digitally by healthcare professionals. This approach builds on extensive clinical research and offers a more flexible and scalable alternative to current hospital-based treatments.
INSAI, The Nexus Neuromudulation Headband
Call 2 - 2022
500.000 DKK
Clinical Area
Neurology
Technology
Med Tech, Monitoring, Wearable brain stimulation
PROJECT SUMMARY
INSAI is developing a wearable device for brain monitoring and gentle stimulation to treat major depressive disorder. The solution allows patients to receive safe, personalized therapy at home with remote supervision, making advanced depression treatment more accessible and less dependent on hospital visits
CLINICAL IMPACT
The technology can reduce the need for heavy medication and its side effects, while giving patients the freedom to continue their daily lives during treatment. It can shorten the time from first-line to effective second-line therapy, improve treatment outcomes, and may also be adapted for other conditions like OCD, ADHD, and substance use disorders.